Postoperative nomogram to predict cancer‐specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis
Open Access
- 21 January 2014
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 114 (5), 733-740
- https://doi.org/10.1111/bju.12631
Abstract
Objective To propose and validate a nomogram to predict cancer‐specific survival (CSS) after radical nephroureterectomy (RNU) in patients with pT1–3/N0–x upper tract urothelial carcinoma (UTUC). Patients and Methods The international and the French national collaborative groups on UTUC pooled data from 3387 patients treated with RNU. Only 2233 chemotherapy naïve pT1–3/N0–x patients were included in the present study. The population was randomly split into the development cohort (1563) and the external validation cohort (670). To build the nomogram, logistic regressions were used for univariable and multivariable analyses. Different models were generated. The most accurate model was assessed using Harrell's concordance index and decision curve analysis (DCA). Internal validation was then performed by bootstrapping. Finally, the nomogram was calibrated and externally validated in the external dataset. Results Of the 1563 patients in the nomogram development cohort, 309 (19.7%) died during follow‐up from UTUC. The actuarial CSS probability at 5 years was 75.7% (95% confidence interval [CI] 73.2–78.6%). DCA revealed that the use of the best model was associated with benefit gains relative to prediction of CSS. The optimised nomogram included only six variables associated with CSS in multivariable analysis: age (P < 0.001), pT stage (P < 0.001), grade (P < 0.02), location (P < 0.001), architecture (P < 0.001) and lymphovascular invasion (P < 0.001). The accuracy of the nomogram was 0.81 (95% CI, 0.78–0.85). Limitations included the retrospective study design and the lack of a central pathological review. Conclusion An accurate postoperative nomogram was developed to predict CSS after RNU only in locally and/or locally advanced UTUC without metastasis, where the decision for adjuvant treatment is controversial but crucial for the oncological outcome.Keywords
This publication has 23 references indexed in Scilit:
- European Guidelines on Upper Tract Urothelial Carcinomas: 2013 UpdateEuropean Urology, 2013
- Prediction of Cancer Specific Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Development of an Optimized Postoperative Nomogram Using Decision Curve AnalysisJournal of Urology, 2012
- Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate TwinsJournal of Urology, 2012
- Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) – opening of the peri‐operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) TrialBJU International, 2012
- Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogramBritish Journal of Cancer, 2012
- Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaEuropean Urology, 2012
- Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC)Cancer, 2011
- Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma CollaborationJournal of Urology, 2009
- Behavior of Urothelial Carcinoma With Respect to Anatomical LocationJournal of Urology, 2007
- Multifocal Urothelial Cancers With the Mutator Phenotype are of Monoclonal Origin and Require Panurothelial Treatment for Tumor ClearanceJournal of Urology, 2006